ArticleInfectious diseases and therapy2023

Pharmacokinetics, Efficacy, and Safety of a SARS-CoV-2 Antibody Treatment in Pediatric Participants: An Open-Label Addendum of a Placebo-Controlled, Randomized Phase 2/3 Trial.

Himanshu P Upadhyaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.